Evidence map›Paper›PMID 33184495›Full record

ArticleMolecular psychiatry2021

How autism and Alzheimer's disease are TrAPPed.

Debomoy K Lahiri, Bryan Maloney, Ruizhi Wang, Deborah K Sokol, Jack T Rogers, Cara J Westmark

Abstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The Neuroimmunology of Autism.Molecular neurobiology · 2025
    Review
  3. Connecting genomic and proteomic signatures of amyloid burden in the brain.medRxiv : the preprint server for health sciences · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Debomoy K LahiriDepartment of Psychiatry and Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA. dlahiri@iupui.edu.ORCID http://orcid.org/0000-0002-1664-5933
Bryan MaloneyDepartment of Psychiatry and Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0003-2364-9649
Ruizhi WangDepartment of Psychiatry and Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Deborah K SokolDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Jack T RogersDepartment of Psychiatry, Neurochemistry lab, MGH, Harvard Medical School, Charlestown, MA, USA.
Cara J WestmarkDepartment of Neurology, University of Wisconsin, Madison, WI, USA.ORCID http://orcid.org/0000-0003-3919-3279

Funding

Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Neurobiological Role of MicroRNA in Alzheimer'sR01AG051086 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 2015 to 2019
$1.9M
Role of microRNA in regulating Fe, Amyloid, and Tau (FeAT) in Alzheimer's diseaseR56AG072810 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 2021 to 2021
$630k
Post Transcriptional Control of hemorrhagic iron damage.R21NS077079 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROGERS, JACK T · 2012 to 2013
$458k
Brain protein alteration by vascular overexpressed miRNA (BravomiR)R21AG076202 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 2022 to 2022
$435k
Testing a Novel Approach to Solve the On-target, Off-site Effects of Alzheimer's DrugsR21AG056007 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 2019 to 2020
$435k
Alzheimer's disease-linked microRNA Exploration of UTR Polymorphisms (AdmiRE-UP)R21AG074539 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 2022 to 2022
$435k
Human MicroRNA as a potential therapeutic target in Alzheimer's disease.R21AG042804 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 2012 to 2013
$411k
NIA NIH HHS P30 AG010133NIA NIH HHS R01 AG051086NIA NIH HHS R21 AG042804NIA NIH HHS R21 AG056007NIA NIH HHS R21 AG074539NIA NIH HHS R21 AG076202NIA NIH HHS R56 AG072810NINDS NIH HHS R21 NS077079
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Age of OnsetAlzheimer DiseaseAmyloid beta-PeptidesAnimalsAutistic DisorderBrainHumansMiceAmyloid beta-Peptides

Identifiers

PMID33184495
PMCPMC9487718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.